RCAMU
DPLO

Rothschild & Co Asset Management US’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Rothschild & Co Asset Management US’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-45,264
Closed -$1.27M – 572
2016
Q3 		$1.27M Buy
+45,264
New +$1.52M 0.02% 338

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Rothschild & Co Asset Management US's DPLO Position: Q4 2016 in Review

Rothschild & Co Asset Management US sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2016, closing a stake of 45,264 shares — an estimated $1.27M sold.

Rothschild & Co Asset Management US first reported a position in DPLO in Q3 2016 and held it in 1 quarter. The position peaked at $1.27M in Q3 2016. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

  • Rothschild & Co Asset Management US reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2016 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 45,264 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $1.27M.
  • Rothschild & Co Asset Management US first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 1 quarter.
  • Rothschild & Co Asset Management US's DIPLOMAT PHARMACY, INC. position peaked at $1.27M in Q3 2016.
  • 174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2016, filed 15 Feb 2017.